Clinical Trial Update: " Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

View source ↗

Summary

A clinical trial from Fayoum University evaluating erythropoietin therapy in end-stage renal disease patients on hemodialysis, focusing on hemoglobin outcomes a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Erythropoietin-resistant Anemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Fayoum University | Conditions: Erythropoietin Resistant Anemia (EPO Resistant Anemia) | Status: NOT_YET_RECRUITING